INS and type 1 diabetes mellitus: One of the main aspects to consider when starting semaglutide or tirzepatide therapy in patients with autoimmune diabetes is the concomitant need for insulin dose adjustments, particularly because there is still no evidence-based insulin titration guidance for semaglutide and tirzepatide use in T1D patients.